Clinical translation of human neural stem cells

Stem Cell Research and Therapy

Volumn 4, Issue 4, 2013, Pages

  Tsukamoto, Ann ^a   Uchida, Nobuko ^a   Capela, Alexandra ^a   Gorba, Thorsten ^a   Huhn, Stephen ^a  

^a StemCells Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAPINEUZUMAB; SOLANEZUMAB;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN; CELL RENEWAL; CEREBROVASCULAR ACCIDENT; CRYOPRESERVATION; DEGENERATIVE DISEASE; EYE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYSOSOME STORAGE DISEASE; NERVE CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PELIZAEUS MERZBACHER DISEASE; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SPINAL CORD; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; CELL DIFFERENTIATION; PROCEDURES; STEM CELL TRANSPLANTATION;

CELL DIFFERENTIATION; HUMANS; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84887904386     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt313     Document Type: Review

References (76)

1. Purification and characterization of mouse hematopoietic stem cells. Spangrude GJ, Heimfeld S, Weissman IL, Science 1988 241 58 62 2898810
2. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Morrison SJ, Weissman IL, Immunity 1994 1 661 673 7541305 (Pubitemid 124000730)
3. Isolation of a candidate human hematopoietic stem-cell population. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B, Proc Natl Acad Sci USA 1992 89 2804 2808 1372992
4. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Morrison SJ, White PM, Zock C, Anderson DJ, Cell 1999 96 737 749 10089888 (Pubitemid 29122815)
5. Isolation and culture of epithelial stem cells. Nowak JA, Fuchs E, Methods Mol Biol 2009 482 215 232 19089359
6. Stem cells, self-renewal, and differentiation in the intestinal epithelium. van der Flier LG, Clevers H, Annu Rev Physiol 2009 71 241 260 18808327
7. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cerletti M, Jurga S, Witczak CA, Hirshman MF, Shadrach JL, Goodyear LJ, Wagers AJ, Cell 2008 134 37 47 18614009 (Pubitemid 351905744)
8. Prospective identification of tumorigenic breast cancer cells. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, Proc Natl Acad Sci USA 2003 100 3983 3988 12629218 (Pubitemid 36418143)
9. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, Lawson D, Chen D, Li Y, Guo C, Zhang B, Fazli L, Gleave M, Witte ON, Garraway IP, Wu H, PLoS One 2012 7 42564 22880034
10. Neurogenesis in the adult human hippocampus. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH, Nat Med 1998 4 1313 1317 9809557 (Pubitemid 28512114)
11. Signaling in adult neurogenesis. Suh H, Deng W, Gage FH, Annu Rev Cell Dev Biol 2009 25 253 275 19575663
12. Mammalian neural stem cells. Gage FH, Science 2000 287 1433 1438 10688783 (Pubitemid 30127128)
13. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, Karmiol S, Dunnett SB, Exp Neurol 1997 148 135 146 9398456 (Pubitemid 127445121)
14. Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats. Brustle O, Choudhary K, Karram K, Huttner A, Murray K, Dubois-Dalcq M, McKay RD, Nat Biotechnol 1998 16 1040 1044 9831032 (Pubitemid 28515896)
15. In vitro expansion of a multipotent population of human neural progenitor cells. Carpenter MK, Cui X, Hu ZY, Jackson J, Sherman S, Seiger A, Wahlberg LU, Exp Neurol 1999 158 265 278 10415135 (Pubitemid 29382819)
16. Direct isolation of human central nervous system stem cells. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL, Proc Natl Acad Sci USA 2000 97 14720 14725 11121071 (Pubitemid 32016642)
17. Adherent neural stem (NS) cells from fetal and adult forebrain. Pollard SM, Conti L, Sun Y, Goffredo D, Smith A, Cereb Cortex 2006 16 112 i120 16766697
18. Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed. Kim HT, Kim IS, Lee IS, Lee JP, Snyder EY, Park KI, Exp Neurol 2006 199 222 235 16714017
19. Neural grafting in Parkinson's disease: problems and possibilities. Brundin P, Barker RA, Parmar M, Prog Brain Res 2010 184 265 294 20887880
20. Clinical application of stem cell therapy in Parkinson's disease. Politis M, Lindvall O, BMC Med 2012 10 1 22216957
21. The current status of neural grafting in the treatment of Huntington's disease. A review. Wijeyekoon R, Barker RA, Front Integr Neurosci 2011 5 78 22162966
22. Division and differentiation of isolated CNS blast cells in microculture. Temple S, Nature 1989 340 471 473 2755510 (Pubitemid 19191283)
23. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Cattaneo E, McKay R, Nature 1990 347 762 765 2172829
24. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Reynolds BA, Weiss S, Science 1992 255 1707 1710 1553558
25. Cloning and growth of multipotential neural precursors: requirements for proliferation and differentiation. Kilpatrick TJ, Bartlett PF, Neuron 1993 10 255 265 8439411 (Pubitemid 23079547)
26. Proliferation, differentiation, and long-term culture of primary hippocampal neurons. Ray J, Peterson DA, Schinstine M, Gage FH, Proc Natl Acad Sci USA 1993 90 3602 3606 8475109 (Pubitemid 23111415)
27. Stem cells in the central nervous system. McKay R, Science 1997 276 66 71 9082987 (Pubitemid 27161244)
28. Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. Tamaki S, Eckert K, He D, Sutton R, Doshe M, Jain G, Tushinski R, Reitsma M, Harris B, Tsukamoto A, Gage F, Weissman I, Uchida N, J Neurosci Res 2002 69 976 986 12205691 (Pubitemid 34984715)
29. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, Capela A, Greve J, Malenka RC, Moseley ME, Palmer TD, Steinberg GK, Proc Natl Acad Sci USA 2007 104 10211 10216 17553967 (Pubitemid 47175288)
30. Modern methods for delivery of drugs across the blood-brain barrier. Chen Y, Liu L, Adv Drug Deliv Rev 2012 64 640 665 22154620
31. Stem cell transplantation for neurometabolic and neurodegenerative diseases. Shihabuddin LS, Aubert I, Neuropharmacology 2010 58 845 854 20036262
32. Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions. Snyder EY, Macklis JD, Clin Neurosci 1995 3 310 316 8914798
33. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Lacorazza HD, Flax JD, Snyder EY, Jendoubi M, Nat Med 1996 2 424 429 8597952 (Pubitemid 26191914)
34. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. Buchet D, Serguera C, Zennou V, Charneau P, Mallet J, Mol Cell Neurosci 2002 19 389 401 11906211 (Pubitemid 34293461)
35. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y, J Neurosci Res 2003 74 266 277 14515356 (Pubitemid 37193713)
36. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology. Shihabuddin LS, Numan S, Huff MR, Dodge JC, Clarke J, Macauley SL, Yang W, Taksir TV, Parsons G, Passini MA, Gage FH, Stewart GR, J Neurosci 2004 24 10642 10651 15564580 (Pubitemid 39557637)
37. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Lee JP, Jeyakumar M, Gonzalez R, Takahashi H, Lee PJ, Baek RC, Clark D, Rose H, Fu G, Clarke J, McKercher S, Meerloo J, Muller FJ, Park KI, Butters TD, Dwek RA, Schwartz P, Tong G, Wenger D, Lipton SA, Seyfried TN, Platt FM, Snyder EY, Nat Med 2007 13 439 447 17351625 (Pubitemid 46559825)
38. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M, He D, Tushinski R, Belichenko PV, Salehi A, Mobley W, Gage FH, Huhn S, Tsukamoto AS, Weissman IL, Uchida N, Cell Stem Cell 2009 5 310 319 19733542
39. Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Jeyakumar M, Lee JP, Sibson NR, Lowe JP, Stuckey DJ, Tester K, Fu G, Newlin R, Smith DA, Snyder EY, Platt FM, Stem Cells 2009 27 2362 2370 19591217
40. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Cooper JD, Russell C, Mitchison HM, Biochim Biophys Acta 2006 1762 873 889 17023146 (Pubitemid 44740126)
41. Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis. Wong AM, Rahim AA, Waddington SN, Cooper JD, Biochem Soc Trans 2010 38 1484 1488 21118112
42. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA, Hammer RE, Hofmann SL, Proc Natl Acad Sci USA 2001 98 13566 13571 11717424 (Pubitemid 33115938)
43. A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. Sleat DE, Wiseman JA, El-Banna M, Kim KH, Mao Q, Price S, Macauley SL, Sidman RL, Shen MM, Zhao Q, Passini MA, Davidson BL, Stewart GR, Lobel P, J Neurosci 2004 24 9117 9126 15483130 (Pubitemid 39372255)
44. Central nervous sytem stem cell transplantation for children with neuronal ceroid lipofuscinosis. Selden NR, Al-Uzri A, Huhn SL, Koch TK, Sikora DM, Nguyen-Driver MD, Guillaume DJ, Koh JL, Gultekin SH, Anderson JC, Vogel H, Sutcliffe TL, Jacobs Y, Steiner RD, J Neurosurg Pediatr 2013 11 643 652 23581634
45. Long-term survival and migration of allogeneic human central nervous system stem cells following intracerebral transplantation in neuronal ceroid lipofuscinosis [abstract]. Jacobs Y, Selden N, Al-Uzri A, Koch T, Vogel H, Huhn S, Uchida N, Dalma-Weiszhausz D, Tsukamoto A, Steiner R, ISSCR 2011 Annual Meeting; Toronto, ON, Canada: June 2011, page 44 [ http://www.isscr.org/docs/ default-source/am2011/isscr-2011-friday-abstracts.pdf?sfvrsn=2 ]
46. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphray S, Saffrey P, Kingsbury Z, Weir JC, Betley J, Grocock RJ, Margulies EH, Farrow EG, Artman M, Safina NP, Petrikin JE, Hall KP, Kingsmore SF, Sci Transl Med 2012 4 154ra135 23035047
47. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Uchida N, Chen K, Dohse M, Hansen KD, Dean J, Buser JR, Riddle A, Beardsley DJ, Wan Y, Gong X, Nguyen T, Cummings BJ, Anderson AJ, Tamaki SJ, Tsukamoto A, Weissman IL, Matsumoto SG, Sherman LS, Kroenke CD, Back SA, Sci Transl Med 2012 4 155ra136 23052293
48. Stem cell-based strategies for treating pediatric disorders of myelin. Goldman SA, Schanz S, Windrem MS, Hum Mol Genet 2008 17 76 R83 18632701
49. Cell-based therapies for disorders of the brain and spinal cord. Goldman SA, Sim FJ, Neurotherapeutics 2011 8 537 538 21989674
50. The myelin mutants as models to study myelin repair in the leukodystrophies. Duncan ID, Kondo Y, Zhang SC, Neurotherapeutics 2011 8 607 624 21979830
51. Tracing transplanted oligodendrocytes during migration and maturation in the shiverer mouse brain. Gansmuller A, Clerin E, Kruger F, Gumpel M, Lachapelle F, Glia 1991 4 580 590 1720763
52. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Yandava BD, Billinghurst LL, Snyder EY, Proc Natl Acad Sci USA 1999 96 7029 7034 10359833 (Pubitemid 29275004)
53. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G, Roy NS, Goldman SA, Nat Med 2004 10 93 97 14702638 (Pubitemid 38524704)
54. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R, Gage FH, Anderson AJ, Proc Natl Acad Sci USA 2005 102 14069 14074 16172374 (Pubitemid 41377704)
55. Directing human neural stem/precursor cells into oligodendrocytes by overexpression of Olig2 transcription factor. Maire CL, Buchet D, Kerninon C, Deboux C, Baron-Van Evercooren A, Nait-Oumesmar B, J Neurosci Res 2009 87 3438 3446 19739249
56. Human neural progenitors from different foetal forebrain regions remyelinate the adult mouse spinal cord. Buchet D, Garcia C, Deboux C, Nait-Oumesmar B, Baron-Van Evercooren A, Brain 2011 134 1168 1183 21459827
57. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Windrem MS, Schanz SJ, Guo M, Tian GF, Washco V, Stanwood N, Rasband M, Roy NS, Nedergaard M, Havton LA, Wang S, Goldman SA, Cell Stem Cell 2008 2 553 565 18522848 (Pubitemid 351729215)
58. CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells. Sim FJ, McClain CR, Schanz SJ, Protack TL, Windrem MS, Goldman SA, Nat Biotechnol 2011 29 934 941 21947029
59. Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Garbern JY, Cell Mol Life Sci 2007 64 50 65 17115121 (Pubitemid 46159445)
60. Neural stem cell engraftment and myelination in the human brain. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, Caverzasi E, Gaetano L, Mandelli ML, Ryan T, Perry R, Farrell J, Jeremy RJ, Ulman M, Huhn SL, Barkovich AJ, Rowitch DH, Sci Transl Med 2012 4 155ra137 23052294
61. Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Cummings BJ, Uchida N, Tamaki SJ, Anderson AJ, Neurol Res 2006 28 474 481 16808875 (Pubitemid 44141313)
62. Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. Hooshmand MJ, Sontag CJ, Uchida N, Tamaki S, Anderson AJ, Cummings BJ, PLoS One 2009 4 5871 19517014
63. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. Salazar DL, Uchida N, Hamers FP, Cummings BJ, Anderson AJ, PLoS One 2010 5 12272 20806064
64. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisen J, Olson L, Nat Neurosci 2005 8 346 353 15711542 (Pubitemid 40300192)
65. Pluripotent human stem cells for the treatment of retinal disease. Rowland TJ, Buchholz DE, Clegg DO, J Cell Physiol 2012 227 457 466 21520078
66. Stem cells for retinal replacement therapy. Stern JH, Temple S, Neurotherapeutics 2012 8 736 743
67. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Wang S, Girman S, Lu B, Bischoff N, Holmes T, Shearer R, Wright LS, Svendsen CN, Gamm DM, Lund RD, Invest Ophthalmol Vis Sci 2008 49 3201 3206 18579765
68. Transplantation of human central nervous system stem cells- neuroprotection in retinal degeneration. McGill TJ, Cottam B, Lu B, Wang S, Girman S, Tian C, Huhn SL, Lund RD, Capela A, Eur J Neurosci 2012 35 468 477 22277045
69. Neural stem cells improve memory in an inducible mouse model of neuronal loss. Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM, J Neurosci 2007 27 11925 11933 17978032 (Pubitemid 350072121)
70. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM, Neuron 2003 39 409 421 12895417 (Pubitemid 36937044)
71. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM, Proc Natl Acad Sci USA 2009 106 13594 13599 19633196
72. Concise review: can stem cells be used to treat or model Alzheimer disease? Chen WW, Blurton-Jones M, Stem Cells 2012 30 2612 2618 22997040
73. Restoration of memory in mouse models of Alzheimer disease and neuronal loss: a new paradigm using human neural stem cell transplantation [abstract]. Blurton-Jones M, Ager R, Nerhus J, Agazaryan A, Huhn S, Capela A, LaFerla F, Alzheimer's Association International Conference 2012 [ http://download. journals.elsevierhealth.com/pdfs/journals/1552-5260/PIIS1552526012017013.pdf ]
74. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Carlson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, Eckman C, Meiners J, Nilsen SP, Younkin SG, Hsiao KK, Hum Mol Genet 1997 6 1951 1959 9302276 (Pubitemid 27460373)
75. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D, J Biol Chem 2001 276 21562 21570 11279122 (Pubitemid 37413154)
76. Quantifying amyloid beta (Abeta)-mediated changes in neuronal morphology in primary cultures: implications for phenotypic screening. Nguyen L, Wright S, Lee M, Ren Z, Sauer JM, Hoffman W, Zago W, Kinney GG, Bova MP, J Biomol Screen 2012 17 835 842 22473881